Streptavidin-drug conjugates streamline optimization of antibody-based hematopoietic stem cell transplant conditioning

Authors

Aditya R Yelamali, Washington University School of Medicine in St. Louis
Ezhilarasi Chendamarai, Washington University School of Medicine in St. Louis
Julie K Ritchey, Washington University School of Medicine in St. Louis
Michael P Rettig, Washington University School of Medicine in St. Louis
John F DiPersio, Washington University School of Medicine in St. Louis
Stephen P Persaud, Washington University School of Medicine in St. Louis

Journal

Blood Immunology & Cellular Therapy

Publication Date

12-1-2025

Volume

1

Issue

3

First Page

100012

Document Type

Open Access Publication

DOI

10.1016/j.bict.2025.100012

Rights and Permissions

Yelamali AR, Chendamarai E, Ritchey JK, Rettig MP, DiPersio JF, Persaud SP. Streptavidin-drug conjugates streamline optimization of antibody-based hematopoietic stem cell transplant conditioning. Blood Immunol Cell Ther. 2025 Dec;1(3):1000012. doi: 10.1016/j.bict.2025.100012. © 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Recommended Citation

Yelamali, Aditya R; Chendamarai, Ezhilarasi; Ritchey, Julie K; Rettig, Michael P; DiPersio, John F; and Persaud, Stephen P, "Streptavidin-drug conjugates streamline optimization of antibody-based hematopoietic stem cell transplant conditioning." Blood Immunology & Cellular Therapy. 1, 3. 100012 (2025).
https://digitalcommons.wustl.edu/oa_4/6324

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.